Application Notes Supplement 2021
Posted: 29 June 2021 | European Pharmaceutical Review | No comments yet
Here, industry experts share their research, guidance and pharmaceutical knowledge.
Welcome to European Pharmaceutical Review’s Application Notes Supplement 2021.
In this edition, Shimadzu covers software that makes data integrity compliance visible; Nelson Labs looks at the Monocyte Activation Assay and highlights the benefits of an animal-free test to show pyrogen-free pharmaceutical products; and Nemera showcases the development of the company’s pen injector platforms and how they are tailored to meet customers’ and patients’ needs.
Issue
Related topics
Analytical techniques, Data integrity, Drug Delivery Systems, Drug Development, Endotoxin Detection, Industry Insight, Informatics, Medical Devices, QA/QC, Regulation & Legislation, Research & Development (R&D)